AHR |
P35869
|
aryl hydrocarbon receptor
|
Transcription factor
|
1.00 |
0.410 |
0.923 |
ATXN2 |
Q99700
|
ataxin 2
|
Nucleic acid binding
|
0.85 |
0.482 |
0.808 |
BACH2 |
Q9BYV9
|
BTB domain and CNC homolog 2
|
|
1.00 |
0.539 |
0.731 |
BAK1 |
Q16611
|
BCL2 antagonist/killer 1
|
Signaling
|
7.4E-06 |
0.555 |
0.769 |
BAX |
Q07812
|
BCL2 associated X, apoptosis regulator
|
Signaling
|
0.32 |
0.417 |
0.885 |
BCL2 |
P10415
|
BCL2 apoptosis regulator
|
Signaling
|
0.56 |
0.291 |
0.885 |
CCR3 |
P51677
|
C-C motif chemokine receptor 3
|
G-protein coupled receptor
|
1.3E-04 |
0.527 |
0.808 |
CD226 |
Q15762
|
CD226 molecule
|
|
3.9E-02 |
0.548 |
0.769 |
CD247 |
P20963
|
CD247 molecule
|
|
1.7E-02 |
0.539 |
0.731 |
CD28 |
P10747
|
CD28 molecule
|
|
0.36 |
0.436 |
0.885 |
CD86 |
P42081
|
CD86 molecule
|
|
0.95 |
0.483 |
0.769 |
CDKN2A |
P42771 Q8N726
|
cyclin dependent kinase inhibitor 2A
|
|
0.39 |
0.300 |
0.885 |
CLC |
Q05315
|
Charcot-Leyden crystal galectin
|
Signaling
|
2.3E-05 |
0.650 |
0.731 |
CLEC16A |
Q2KHT3
|
C-type lectin domain containing 16A
|
|
0.28 |
0.612 |
0.654 |
CNR2 |
P34972
|
cannabinoid receptor 2
|
G-protein coupled receptor
|
6.5E-06 |
0.509 |
0.846 |
DLEU1 |
O43261
|
deleted in lymphocytic leukemia 1
|
|
0.47 |
0.569 |
0.692 |
ELMO1 |
Q92556
|
engulfment and cell motility 1
|
Signaling
|
0.90 |
0.608 |
0.615 |
ETS1 |
P14921
|
ETS proto-oncogene 1, transcription factor
|
Transcription factor
|
0.78 |
0.444 |
0.731 |
FAAH |
O00519
|
fatty acid amide hydrolase
|
|
4.4E-11 |
0.545 |
0.692 |
GATA3 |
P23771
|
GATA binding protein 3
|
|
0.90 |
0.415 |
0.846 |
GLB1 |
P16278
|
galactosidase beta 1
|
Enzyme
|
7.9E-10 |
0.448 |
0.808 |
GPR35 |
Q9HC97
|
G protein-coupled receptor 35
|
G-protein coupled receptor
|
4.9E-03 |
0.587 |
0.654 |
HECTD4 |
Q9Y4D8
|
HECT domain E3 ubiquitin protein ligase 4
|
|
1.00 |
0.700 |
0.462 |
HLA-A |
P04439
|
major histocompatibility complex, class I, A
|
|
1.3E-03 |
0.370 |
0.846 |
HLA-B |
P01889
|
major histocompatibility complex, class I, B
|
|
3.9E-05 |
0.379 |
0.885 |